Particulars (Rupees in Crores.) | Sept-2024 | Jun-2024 | Mar-2024 | Dec-2023 | Sept-2023 |
---|---|---|---|---|---|
Gross Sales | 430.67 | 361.84 | 450.13 | 377.92 | 302.28 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 430.67 | 361.84 | 450.13 | 377.92 | 302.28 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 11.07 | 3.98 | 2.99 | 3.1 | 1.32 |
Total Income | 441.74 | 365.82 | 453.12 | 381.02 | 303.6 |
Total Expenditure | 324.09 | 276.83 | 316.32 | 281.65 | 247.76 |
PBIDT | 117.65 | 88.99 | 136.81 | 99.37 | 55.84 |
Interest | 9.02 | 11.02 | 20.7 | 23.55 | 24.86 |
PBDT | 108.63 | 77.97 | 116.11 | 75.82 | 30.99 |
Depreciation | 9.22 | 8.41 | 8.48 | 8.65 | 7.96 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 22.88 | 16.06 | 20.78 | 18.62 | 6.95 |
Deferred Tax | 0.66 | 2.58 | -12.8 | 0.51 | -0.68 |
Reported Profit After Tax | 75.88 | 50.92 | 99.64 | 48.04 | 16.76 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 75.88 | 50.92 | 99.64 | 48.04 | 16.76 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 75.88 | 50.92 | 99.64 | 48.04 | 16.76 |
EPS (Unit Curr.) | 3.33 | 2.24 | 4.45 | 2.45 | 0.93 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 45.49 | 45.49 | 45.49 | 39.44 | 39.15 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 27.31 | 24.59 | 30.39 | 26.29 | 18.47 |
PBDTM(%) | 25.22 | 21.54 | 25.79 | 20.06 | 10.25 |
PATM(%) | 17.61 | 14.07 | 22.13 | 12.71 | 5.54 |
At the end of the June quarter, Paresh owned 1.12% of Sun Pharma Advanced Research, while his brother Vijay owned 1.13% of the company.
Here are some of the stocks that may see significant price movement today: HPCL, PNB Housing, Colgate-Palmolive, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.